Lanzamiento Enero 2027

Ensayo controlado aleatorizado2015Solo mecanismosAcceso abierto

Dietary Omega-3 Fatty Acid Supplementation Reduces Inflammation in Obese Pregnant Women: A Randomized Double-Blind Controlled Clinical Trial

Haghiac M, Yang XH, Presley L, Smith S, Dettelback S, Minium J, Belury MA, Catalano PM, Hauguel-de Mouzon S

PloS one · 116 citas

Etiquetas de revisión

Solo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas, más trabajo en animales o laboratorio
Resultado principal
Solo mecanismos

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Institutes of Health
Gobierno
U.S. Public Health Service
Gobierno
National Center for Advancing Translational Sciences
Gobierno
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Gobierno
NICHD NIH HHS
Gobierno
NCATS NIH HHS
Gobierno
PHS HHS
Subvenciones
National Center for Advancing Translational Sciences (UL1-TR-000439); U.S. Public Health Service (RHD057236); Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD057236); National Institutes of Health (RHD057236)

Según 7 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2015-09-04 · PLoS One · vol. 10 · número 9 · pág. e0137309
Editorial
Public Library of Science
Citado
140 citas · más que el 99% de estudios similares · 11.7× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
50 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Fatty Acid Research and Health · Birth, Development, and Health · Pregnancy and preeclampsia studies
Palabras clave
omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, maternal obesity, inflammation, placenta, adipose tissue, TLR4, interleukin-6, interleukin-8, TNF-α, C-reactive protein, n-6/n-3 ratio, trophoblast, palmitate, dietary supplementation
MeSH
adipose tissue, trophoblasts, placenta, humans, obesity, inflammation, docosahexaenoic acids, eicosapentaenoic acid, interleukin-8, interleukin-6, diet, double-blind method, signal transduction, gene expression regulation, pregnancy, dietary supplements, adult, female, toll-like receptor 4, primary cell culture

9 autores

  • Maricela Haghiac🇺🇸MetroHealth; MetroHealth Medical Center
  • Xiao-hua Yang🇺🇸MetroHealth; MetroHealth Medical Center
  • Larraine Huston Presley🇺🇸MetroHealth; MetroHealth Medical Center
  • Shoi Smith🇺🇸MetroHealth; MetroHealth Medical Center
  • Shirley Dettelback🇺🇸MetroHealth; MetroHealth Medical Center
  • Judi Minium🇺🇸MetroHealth; MetroHealth Medical Center
  • Martha Ann Belury🇺🇸The Ohio State University
  • Patrick M. Catalano🇺🇸MetroHealth; MetroHealth Medical Center
  • Sylvie Hauguel‐de Mouzon🇺🇸 · autor de correspondenciaMetroHealth; MetroHealth Medical Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective

Long-chain omega 3 fatty acids, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) exert potent anti-inflammatory properties in humans. This study characterized the effects of omega-3 ω-3 fatty acids supplements (ω-3 FA) on the inflammatory status in the placenta and adipose tissue of overweight/obese pregnant women.

Study design

A randomized, double-masked controlled trial was conducted in overweight/obese pregnant women that were randomly assigned to receive DHA plus EPA (2 g/day) or the equivalent of a placebo twice a day from week 10-16 to term. Inflammatory pathways were characterized in: 1) adipose tissue and placenta of treated vs. untreated women; and 2) adipose and trophoblast cells cultured with long chain FAs.

Results

The sum of plasma DHA and EPA increased by 5.8 fold and ω-3 FA/ω-6 FA ratio was 1.5 in treated vs. untreated women (p< 0.005). Plasma CRP concentrations were reduced (p<0.001). The adipose tissue and placenta of treated women exhibited a significant decrease in TLR4 adipose and placental expression as well as IL6, IL8, and TNFα In vitro, EPA and DHA suppressed the activation of TLR4, IL6, IL8 induced by palmitate in culture of adipose and trophoblast cells.

Conclusion

Supplementation of overweight/obese pregnant women with dietary ω-3 FAs for >25 weeks reduced inflammation in maternal adipose and the placental tissue. TLR4 appears as a central target of the anti-inflammatory effects at the cellular level.

Trial registration

ClinicalTrials.gov NCT00957476.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.